Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

It's a trademark, not a patent.

However, Elite does have issued patents and pending patents.

Patents

-- "Since our incorporation, we have secured the following patents, of which two have been assigned for a fee to another pharmaceutical company."

Our patents are:

PATENT / EXPIRATION DATE

U.S. patent 6,620,439 October 2020
U.S. patent 6,926,909 April 2023
U.S. patent 8,182,836 April 2024
U.S. patent 8,425,933 April 2024
U.S. patent 8,703,186 April 2024
Canadian patent 2,521,655 April 2024
Canadian patent 2,541,371 September 2024
U.S. patent 9,056,054 June 2030
E.P. patent 1615623 April 2024
U.S. patent 10213388 April 2030

-- We also have pending applications for two additional U.S. patents non-provisional patents and one provisional patent application and one foreign patent application.

-- We intend to apply for patents for other products in the future; however, there can be no assurance that any of the pending applications or other applications which we may file will be granted. We have also filed corresponding foreign applications for key patents.